Camino Real Capital Partners

Camino Real Capital Partners, LLC is a private equity firm based in Santa Fe, New Mexico, that focuses on strategic acquisitions in the United States, particularly in New Mexico. The firm targets innovators and emerging technologies, emphasizing transformative technology, medical device and life science advancements, as well as service providers in the energy sector. It typically invests between $0.25 million and $10 million in transactions valued from $0.5 million to $50 million. Camino Real Capital Partners seeks to support companies that have limited access to private investment, providing essential capital to foster growth and innovation.

Thomas Nickoloff

Founder and Managing Principal

3 past transactions

Autonomic Materials

Venture Round in 2022
Autonomic Materials, Inc. specializes in the design, manufacturing, and marketing of self-healing solutions specifically tailored for the coatings industry. The company offers a range of microencapsulated additives, including dual capsule systems utilizing reactive silicone polymers and single capsule systems that promote the curing of epoxy resin and facilitate cross-linking in functionalized alkyd resins. These innovative products provide enhanced protection for various substrates, including metals, wood, concrete, plastics, and composites. Applications of Autonomic Materials' solutions span diverse sectors such as alternative energy, industrial maintenance, military equipment, infrastructure, and consumer paints. Founded in 2005 and headquartered in Champaign, Illinois, the company aims to improve the durability and longevity of materials through its advanced self-healing technologies.
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.
BroadSpot Imaging Corporation is developing a suite of diagnostic medical devices for eye care. They leverage advanced imaging technologies and small-scale, cloud-connected electronics to replace bulky, expensive diagnostic instruments with cost-effective handheld instruments and a series of valuable services. their technologies will fundamentally improve how eye care is delivered worldwide: eye doctors can see patients more efficiently, for less money, and more patients will gain access to high quality diagnostics as the population ages.